NEW YORK, March 6 - Looking to validate its database and take another step toward drug discovery, AxCell Biosciences has signed a letter of intent with Thomas Jefferson University to study protein interactions linked to an undisclosed tumor-suppressor gene, the company said on Wednesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.